David P. Luci
Co-Founder, President, CEO, Corporate Secretary & DirectorMr. David P. Luci, CPA, J.D. Esq., also known as Dave, served as Chairman of the Board at AMERI Holdings, Inc. since August 16, 2018 until December 12, 2018. Mr. Luci is the Co-Founder of Acurx Pharmaceuticals, LLC and was its Managing Director from February 2018 until June 2021. He is President and Chief Executive Officer at Acurx Pharmaceuticals, Inc and as its Director since February 2018; and also serves as its Corporate Secretary. He is an Independent Director of AMERI Holdings, Inc. since February 8, 2018. Mr. Luci serves as Co-Founder, Managing Partner and a director of Acurx Pharmaceuticals, LLC. He Co-founded Dipexium Pharmaceuticals, Inc. in 2010 and served as its Managing Partner from 2010 to March 2013. Mr. Luci served as the Chief Executive Officer, President and Secretary at Dipexium Pharmaceuticals, Inc. from February 2010 until April 2017. Mr. Luci served as Principal Financial Officer and Principal Accounting Officer at Dipexium Pharmaceuticals, Inc. Mr. Luci is a life sciences executive with management experience co-founding and managing both private and public biopharmaceutical companies in various senior executive positions, including as a member of the board of directors, President, Chief Business Officer, Chief Financial Officer and General Counsel. He is responsible for over 110 million in equity financing. Further, he negotiated and drafted numerous international licensing and co-development transactions and structured and negotiated several merger transactions, including the sale of a multi-national oncology-based commercial enterprise for 345 mm (2007). He served as the Chief Business Officer and President at MacroChem Corporation from April 22, 2008 to February 25, 2009. He served as Company Secretary, General Counsel and Vice President of Corporate Development of MacroChem Corporation until April 2008 and also served as its Chief Financial Officer from March 19, 2008 to April 2008. He served as an Executive Vice President of Bioenvision, Inc. from November 2006 to July 27, 2007 and served as its Corporate Secretary and General Counsel from July 2002 to July 27, 2007. He served as the Director of Finance of Bioenvision Inc. from July 2002 to July 2004, Chief Financial Officer since July 2004 and also as Principal Accounting Officer. He was employed with Bioenvision Inc. since July 22, 2002. He has raised over 180 million in equity capital over the past 15 years in a senior executive capacity and has lead the disposition of three early stage companies including two Nasdaq listed companies and one OTC BB company, in each case, in the health care sector. From September 1994 to July 2002, he served as a Corporate Associate at Paul, Hastings, Janofsky & Walker LLP. He served as a Senior Auditor/Auditor of Healthcare Practice Group at Ernst & Young LLP (New York office). He began his career with Ernst & Young LLP (New York Office) as a certified public accountant working in the Healthcare Practice Group; transitioned to practicing Corporate Securities lawyer at Paul Hastings (New York Office), a full service international law firm, where his practice encompassed all aspects of public and private mergers and acquisitions, corporate finance, restructurings and private equity transactions, with a core focus in the healthcare industry. He was Director of AMERI Holdings, Inc. since February 8, 2018 until March 28, 2019. He has been a Director of Dipexium Pharmaceuticals, LLC since March 2014. He served as a Member of Advisory Board at AMERI Holdings, Inc. He served as a Director at PLx Pharma Inc. from April 19, 2017 to October 26, 2017. He served as a Director of Abeona Therapeutics Inc. from January 8, 2007 to February 12, 2010. He served as a Director of MacroChem Corp. from December 2007 to February 25, 2009. He is a Certified Public Accountant. He is a member of the New York Bar Association and a Certified Public Accountant (Pennsylvania). He served as Managing Editor of the Journal of Science & Technology Albany Law School of Union University. He holds a Bachelor of Science in Business Administration with a concentration in accounting from Bucknell University and a J.D. from Albany Law School of Union University. Mr. Luci also serves as Chairman of Digital Prime Technologies. From February 2009 to January 2010, Mr. Luci served as a member of the board of directors of Access.
公司职务
- 公司名称Acurx Pharmaceuticals, Inc.股票代码ACXP职务Co-Founder, President, CEO, Corporate Secretary & Director
